BON Announces Nasdaq Compliance
Bon Natural Life (Nasdaq: BON), a bio-ingredient solution provider in the natural, health and personal care industry, has successfully regained compliance with Nasdaq's continued listing requirements. The company received formal confirmation from the Nasdaq Hearings Panel on July 2, 2025, verifying that BON has met the Minimum Bid Price Requirement under Nasdaq Listing Rule 5550(a)(2).
Following BON's compliance plan submission on May 16, 2025, and a hearing presentation on June 5, 2025, the Panel granted the company's request to maintain its Nasdaq Capital Market listing. BON will remain under a Discretionary Panel Monitor for one year to ensure ongoing compliance with listing standards.
Bon Natural Life (Nasdaq: BON), fornitore di soluzioni bio-ingredienti nel settore naturale, della salute e della cura personale, ha riconquistato con successo la conformit脿 ai requisiti di quotazione continuativa del Nasdaq. La societ脿 ha ricevuto la conferma ufficiale dal Nasdaq Hearings Panel il 2 luglio 2025, attestando che BON ha soddisfatto il requisito del prezzo minimo per azione previsto dalla Regola di Quotazione Nasdaq 5550(a)(2).
Dopo la presentazione del piano di conformit脿 di BON il 16 maggio 2025 e l鈥檃udizione del 5 giugno 2025, il Panel ha concesso la richiesta dell鈥檃zienda di mantenere la quotazione sul Nasdaq Capital Market. BON rester脿 sotto la supervisione di un Discretionary Panel Monitor per un anno, a garanzia del rispetto continuo degli standard di quotazione.
Bon Natural Life (Nasdaq: BON), proveedor de soluciones bioingredientes en la industria natural, de salud y cuidado personal, ha recuperado con 茅xito el cumplimiento de los requisitos continuos de cotizaci贸n del Nasdaq. La compa帽铆a recibi贸 la confirmaci贸n formal del Nasdaq Hearings Panel el 2 de julio de 2025, verificando que BON cumpli贸 con el Requisito de Precio M铆nimo seg煤n la Regla de Cotizaci贸n Nasdaq 5550(a)(2).
Tras la presentaci贸n del plan de cumplimiento de BON el 16 de mayo de 2025 y la audiencia del 5 de junio de 2025, el Panel aprob贸 la solicitud de la compa帽铆a para mantener su cotizaci贸n en el Nasdaq Capital Market. BON permanecer谩 bajo la supervisi贸n de un Discretionary Panel Monitor durante un a帽o para asegurar el cumplimiento continuo de las normas de cotizaci贸n.
Bon Natural Life (雮橃姢雼�: BON)電� 鞛愳棸, 瓯搓皶 氚� 臧滌澑 甏�毽� 靷办梾鞚� 氚旍澊鞓� 靹彪秳 靻旊（靺� 鞝滉车鞐呾泊搿滌劀 雮橃姢雼� 靸侅灔 鞙犾 鞖旉贝鞚� 靹标车鞝侅溂搿� 於╈”頄堨姷雼堧嫟. 須岇偓電� 2025雲� 7鞗� 2鞚� 雮橃姢雼� 鞁潣鞙勳洂須岆攵�韯� BON鞚� 雮橃姢雼� 靸侅灔 攴滌箼 5550(a)(2)鞐� 霐半ジ 斓滌爛 鞛呾鞍 臧�瓴� 鞖旉贝鞚� 於╈”頄堨潓鞚� 瓿奠嫕 頇曥澑氚涭晿鞀惦媹雼�.
叠翱狈鞚赌 2025雲� 5鞗� 16鞚�鞐� 欷�靾� 瓿勴殟鞚� 鞝滌稖頃橁碃 2025雲� 6鞗� 5鞚� 觳須� 氚滍憸毳� 頃� 頉�, 鞙勳洂須岆攵�韯� 雮橃姢雼� 鞛愲掣鞁滌灔 靸侅灔鞚� 鞙犾頃� 靾� 鞛堧姅 鞀轨澑鞚� 氚涭晿鞀惦媹雼�. 叠翱狈鞚赌 靸侅灔 旮办鞚� 歆�靻嶌爜鞚� 欷�靾橂ゼ 氤挫灔頃橁赴 鞙勴暣 1雲� 霃欖晥 鞛焿 鞙勳洂須� 氇媹韯办潣 臧愲弲鞚� 氚涥矊 霅╇媹雼�.
Bon Natural Life (Nasdaq : BON), fournisseur de solutions bio-ingr茅dients dans les secteurs naturel, sant茅 et soins personnels, a r茅ussi 脿 retrouver la conformit茅 aux exigences de cotation continue du Nasdaq. La soci茅t茅 a re莽u la confirmation officielle du Nasdaq Hearings Panel le 2 juillet 2025, attestant que BON a satisfait 脿 l'exigence de prix minimum selon la r猫gle de cotation Nasdaq 5550(a)(2).
Suite 脿 la soumission du plan de conformit茅 de BON le 16 mai 2025 et 脿 une audition le 5 juin 2025, le Panel a accord茅 la demande de la soci茅t茅 de maintenir sa cotation sur le Nasdaq Capital Market. BON restera sous la surveillance d'un Discretionary Panel Monitor pendant un an afin d'assurer le respect continu des normes de cotation.
Bon Natural Life (Nasdaq: BON), ein Anbieter von Bio-Inhaltsstoffl枚sungen in der Natur-, Gesundheits- und K枚rperpflegebranche, hat erfolgreich die Einhaltung der fortlaufenden Notierungsanforderungen der Nasdaq wiedererlangt. Das Unternehmen erhielt am 2. Juli 2025 eine formelle Best盲tigung vom Nasdaq Hearings Panel, dass BON die Mindestgebotspreisanforderung gem盲脽 Nasdaq Listing Rule 5550(a)(2) erf眉llt hat.
Nach Einreichung des Compliance-Plans von BON am 16. Mai 2025 und einer Anh枚rung am 5. Juni 2025 genehmigte das Panel den Antrag des Unternehmens, die Notierung am Nasdaq Capital Market beizubehalten. BON wird f眉r ein Jahr unter der Aufsicht eines Discretionary Panel Monitor stehen, um die fortlaufende Einhaltung der Notierungsstandards sicherzustellen.
- Successfully regained Nasdaq listing compliance
- Maintained listing on Nasdaq Capital Market
- Approval of compliance plan by Nasdaq Hearings Panel
- Company will remain under one-year Discretionary Panel Monitor
- Previous non-compliance with minimum bid price requirement
On July 2, 2025, the Company received formal notice from the Nasdaq Hearings Panel confirming that BON has successfully met the Minimum Bid Price Requirement under Nasdaq Listing Rule 5550(a)(2). As a result, the Panel has granted the Company's request to maintain its listing on the Nasdaq Capital Market.
BON submitted its plan of compliance to Nasdaq on May 16, 2025, and subsequently presented its case for continued listing during a hearing on June 5, 2025.
As part of the Panel's decision, BON will remain under a Discretionary Panel Monitor for a period of one year, during which time Nasdaq will monitor the Company's ongoing compliance with all continued listing standards.
About Bon Natural Life Limited ("BON")
BON is a
For more information, please contact:
Cindy听Liu | IR
Email: [email protected]听
Safe Harbor Statement
This press release contains certain statements that may include "forward-looking statements." All statements other than statements of historical fact included herein are "forward-looking statements." These forward-looking statements are often identified by the use of forward-looking terminology such as "believes", "expects" or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, they do involve assumptions, risks, and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.
View original content:
SOURCE Bon Natural Life Limited
FAQ
What did Bon Natural Life (BON) announce regarding Nasdaq compliance on July 14, 2025?
When did BON receive formal notice of Nasdaq compliance?
What monitoring conditions were placed on BON by Nasdaq?
What steps did BON take to regain Nasdaq compliance?
